|
US2002173486A1
|
|
Methods for increasing bulk density of chondroitin
|
|
US2003186967A1
|
|
Acylresorcinol derivatives are selective vitronectin receptor inhibitors
|
|
US2003105313A1
|
|
Aggrecanase molecules
|
|
US2003139468A1
|
|
Amiodarone solutions suitable for intravenous administration
|
|
AU3655802A
|
|
Method and composition for modulating bone growth
|
|
AU4325502A
|
|
Methods and cells for detecting modulators of rgs proteins
|
|
AU3051002A
|
|
Crystal structure of rotavirus nsp4 peptide
|
|
AU2700402A
|
|
Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
|
|
US2002035158A1
|
|
Enantiomers of N-desmethyl venlafaxine
|
|
AU1303702A
|
|
Recombinant mucin binding proteins from steptococcus pneumoniae
|
|
US2002045776A1
|
|
Amino thioxomethyl amino oxyacetic acid derivatives
|
|
AU9491001A
|
|
3-thioxo-(1,2,4)-oxadiazinan-5-one and their use as anti-antherosclerotic agents
|
|
US2002022662A1
|
|
Enantiomers of O-desmethyl venlafaxine
|
|
WO0225276A1
|
|
Crystal structure of bace and uses thereof
|
|
ZA200107633B
|
|
Cyclothiocarbamate derivatives as progesterone receptor modulators.
|
|
AU8313901A
|
|
Method of treating estrogen receptor positive carcinoma
|
|
WO0208201A2
|
|
Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by vla-4
|
|
US2002025973A1
|
|
Phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists
|
|
WO0206283A1
|
|
Improved preparation of (4r, 5s, 6s)-3-(((2r,3r)-2-((((s)-2-amino-3-methyl-1-oxobutyl)methyl)tetrahydro-3-furanyl)thio)-6-((r)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid
|
|
AU7178401A
|
|
Therapy for prosthesis-related bone degeneration
|
